Meobentine sulfate: Antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia
- 1 October 1985
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 110 (4) , 774-784
- https://doi.org/10.1016/0002-8703(85)90456-9
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Myocardial Bethanidine Kinetics After Single-Dose Intravenous Infusion: Correlation with Plasma Kinetics in Closed-Chest DogsJournal of Cardiovascular Pharmacology, 1985
- Plasma Levels of a Novel Antidysrhythmic Agent, Meobentine Sulfate, in Humans as Determined by RadioimmunoassayJournal of Pharmaceutical Sciences, 1982
- The discovery of bretylium and bethanidine.British Journal of Clinical Pharmacology, 1982
- Meobentine sulphate (bis[N-4-methoxybenzyl-N′N″-dimethylguanidine]sulphate): a new antidysrhythmic agentJournal of Pharmacy and Pharmacology, 1981
- Clinical Pharmacokinetics of Intravenous and Oral Bretylium Tosylate in Survivors of Ventricular Tachycardia or FibrillationJournal of Cardiovascular Pharmacology, 1981
- Meobentine sulfate: Antiarrhythmic efficacy and mechanism of action in a chronic canine model of myocardial infarction susceptible to ventricular tachyarrhythmiasThe American Journal of Cardiology, 1981
- Kinetics of antifibrillatory effects of bretylium: Correlation with myocardial drug concentrationsThe American Journal of Cardiology, 1980
- Quantitative comparison of bretylium with other antifibrillatory drugsThe American Journal of Cardiology, 1968
- Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient ComparisonBMJ, 1968
- BRETYLIUM TOSYLATE IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1960